Integrative Health Technologies, Inc. Announces Merger Agreement with Senticore, Inc.
2006年5月26日 - 6:47AM
PRニュース・ワイアー (英語)
SAN ANTONIO, May 25 /PRNewswire/ -- Integrative Health
Technologies, Inc. (IHT) announced the signing of a merger
agreement in which it will become a wholly owned subsidiary of, and
transfer its assets and outstanding shares to, Senticore, Inc.
(OTC:SNIO) (BULLETIN BOARD: SNIO) , a business development company.
IHT and its subsidiary, Health and Medical Research Center, have
been engaged in the research and development of nutritional and
healthcare products and technologies for over 20 years. Relying on
the advice and guidance provided by its highly qualified Scientific
Advisory Board (http://www.ihtglobal.com/), IHT receives grants
from a number of leading companies in the healthcare and nutrition
industries to conduct independent studies of the safety and
efficacy of products and supplements designed to facilitate weight
loss while improving bone health, blood chemistries, and quality of
life. Its assets include a national database of over 40,000
measurements of bone density, lean and fat mass, and blood
chemistries obtained from some of the most sophisticated
technologies available. It contains data from people residing in
every state in the union from measurements obtained from IHT's five
mobile testing units. "The database is a virtual scientific gold
mine for the purpose of examining the relationships between the
various measurements, and can aid in the development of prediction
models designed to personalize nutritional and medical
recommendations to the individual's unique physiological and
biochemical requirements," said Dr. Joel Michalek, a university
professor on IHT's Scientific Advisory Board. "There is no doubt
that the measurements of changes in lean, fat and bone mass
contained in the database are going to have a profound effect on
how we view weight loss," said Dr. Harry G. Preuss, a member of
IHT's Scientific Board, Professor of Medicine at Georgetown
University and former President of the American College of
Nutrition. "We are re-framing the way we think about weight loss
and paying much more attention to the kind, not the amount, of
weight that is lost. Obviously, losing muscle and bone mass is
hardly indicative of healthy weight loss," added Dr. Preuss. The
company has derived its income from ongoing from research and
consulting contracts with its healthcare and nutritional clientele.
As of May 15, 2006, IHT had an un-audited balance sheet indicating
assets of $8,097,515 and liabilities of $522,952. "We need to
underscore the 'un-audited' nature of these figures until we obtain
an independent audit, which will be filed as an amendment to our
Form 8-K within 71 calendar days of closing," said IHT's CEO,
Gilbert R. Kaats, PhD. IHT will become Senticore's largest
portfolio company and, in conjunction with the merger, IHT's
management team will replace Senticore's management after the SEC's
required 10-day waiting period. At that time, the company will
continue to operate as a business development company, but will
limit its acquisitions and its research and development, to the
healthcare and nutritional industries utilizing its networking
connections that have been developed over the past 20 years.
Forward-Looking Statement: Statements that are not historical facts
are forward-looking statements. The Company, through its
management, makes forward-looking public statements concerning its
expected future operations, performance and other developments.
Such forward-looking statements are necessarily estimates
reflecting the Company's best judgment based upon current
information and involve a number of risks and uncertainties, and
there can be no assurance that other factors will not affect the
accuracy of such forward-looking statements. It is impossible to
identify all such factors, factors that could cause actual results
to differ materially from those estimated by the Company. They
include, but are not limited to, government regulation, managing
and maintaining growth, and the effect of adverse publicity,
litigation, competition and other factors that may be identified
from time to time in the Company's public announcements. Contact
Person: Gilbert R. Kaats Integrative Health Technologies, Inc.
(210) 824.4416 DATASOURCE: Integrative Health Technologies, Inc.
CONTACT: Gilbert R. Kaats of Integrative Health Technologies, Inc.,
+1-210-824-4416, Web site: http://www.ihtglobal.com/
Copyright